830 followers
RT @CampbellMDPhD: Thank you, @TusharTarun5, for leading a great, lively @ICOSociety Journal Club discussion of @JACCJournals #CardioOnc pa…
1,847 followers
RT @CampbellMDPhD: Thank you, @TusharTarun5, for leading a great, lively @ICOSociety Journal Club discussion of @JACCJournals #CardioOnc pa…
801 followers
RT @CampbellMDPhD: Thank you, @TusharTarun5, for leading a great, lively @ICOSociety Journal Club discussion of @JACCJournals #CardioOnc pa…
1,247 followers
Thank you, @TusharTarun5, for leading a great, lively @ICOSociety Journal Club discussion of @JACCJournals #CardioOnc paper on Cardiotoxicity Surveillance during HER2-targeted therapy! It's fantastic to hear worldwide perspectives & approaches. https:
685 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
11,574 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
2,807 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
8,097 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
466 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
216 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
1,745 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
232 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
389 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
684 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
725 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
2,731 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
262,959 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
445 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
26,409 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
2,721 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
801 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
2,209 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
11,652 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction o…
105,085 followers
Patients with #LVEF <55% on routine surveillance during #HER2 targeted therapy are at increased risk for LV dysfunction on echo, but is it really the trastuzumab or the anthracyclines? https://t.co/LYcNLOUHgl #JACCCardioOnc #CardioOnc https://t.co/cFLcF
6,852 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
207 followers
RT @ELS_Cardiology: Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy https://t.co/GdQCM3WQBr @JACCJournal…
815 followers
RT @ELS_Cardiology: Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy https://t.co/GdQCM3WQBr @JACCJournal…
32,521 followers
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy https://t.co/GdQCM3WQBr @JACCJournals #breast ancer #cardiac #cardio-oncology #cardiotoxicity #heartfailure https://t.co/Rf65kNr7tW
589 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
32,521 followers
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy https://t.co/XQvXXUvrpR @JACCJournals #breastcancer #cardiac #cardio-oncology #cardiotoxicity #heartfailure https://t.co/UJVVzaSti9
8,097 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
2,998 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
684 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
166 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
677 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
2,483 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
138 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
1,951 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
281 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
113 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
7,870 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
1,372 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
1,542 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
961 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
410 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
1,642 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
801 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
757 followers
RT @JACCJournals: Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartf…
105,085 followers
Patients with #LVEF <55% on routine surveillance during HER2 targeted therapy are at increased risk of developing #heartfailure. Read more in #JACCCardioOnc: https://t.co/LYcNLOUHgl https://t.co/5rooVlDzF6